[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0020-7136&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00017390110001
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
We aimed to systematically evaluate the incidence of inadequate US in hepatocellular carcinoma (HCC)...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway...
Early detection of hepatocellular carcinoma (HCC), whose incidence is ranked as one of the highest a...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[abstract]]OBJECTIVE: Current guidelines recommend screening for hepatocellular carcinoma (HCC) in ...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Early detection of hepatocellular carcinoma (HCC), whose incidence is ranked as one of the highest a...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is associated wi...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
We aimed to systematically evaluate the incidence of inadequate US in hepatocellular carcinoma (HCC)...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway...
Early detection of hepatocellular carcinoma (HCC), whose incidence is ranked as one of the highest a...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[abstract]]OBJECTIVE: Current guidelines recommend screening for hepatocellular carcinoma (HCC) in ...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Early detection of hepatocellular carcinoma (HCC), whose incidence is ranked as one of the highest a...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is associated wi...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
We aimed to systematically evaluate the incidence of inadequate US in hepatocellular carcinoma (HCC)...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...